发明名称 カルバペネム抗生物質中間体の改良された晶析方法
摘要 <p>The present invention relates to an azetidinone compound extremely useful as a common intermediate for the synthesis of 1²-methylcarbapenem compounds. The present invention provides a crystallization method to obtain a crystal which has a higher quality and a higher stability than a conventional crystal and is excellent in filterability at the time of recovering crystal; an azetidinone compound having a low content of impurity; and an azetidinone compound which has a controlled particle size distribution of crystals and improved handleability and stability. The crystallization is carried out by adding a hydrocarbon solvent to a solution in which an azetidinone compound extremely useful as a common intermediate for the synthesis of 1²-methylcarbapenem compounds is dissolved in the presence of a seed crystal in an amount of 200% by weight or less based on the weight of the azetidinone compound. According to the method, the crystal having a high quality and a high stability and excellent filterability at the time of recovering the crystal can be obtained.</p>
申请公布号 JP5671204(B2) 申请公布日期 2015.02.18
申请号 JP20080513151 申请日期 2007.04.18
申请人 发明人
分类号 C07F9/553 主分类号 C07F9/553
代理机构 代理人
主权项
地址